Viewing Study NCT06247423



Ignite Creation Date: 2024-05-06 @ 8:05 PM
Last Modification Date: 2025-12-18 @ 3:43 AM
Study NCT ID: NCT06247423
Status: None
Last Update Posted: 2024-11-08 00:00:00
First Post: 2024-01-22 00:00:00

Brief Title: High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease.
Sponsor: University of Castilla-La Mancha
Organization: University of Castilla-La Mancha

Study Overview

Official Title: Effects of 10kHz High-frequency Alternating Current Transcutaneous Stimulation on Tremor in People with Parkinson's Disease
Status: None
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: High-frequency alternating current (HFAC) stimulation involves applying electrical stimulation with a frequency above 1 kilohertz (kHz) to peripheral nerves, inducing immediate, reversible nerve block without causing damage. Studies have shown that frequencies between 10 and 20 kHz reduce maximal isometric grip strength when applied transcutaneously over peripheral nerves, suggesting a partial block of A-alpha fibers, which may help reduce nerve hyperexcitability and motor activity. Tremor-related pathologies, influenced by abnormal muscle activity, significantly impact the quality of life of patients, particularly those with Parkinson's disease (PD), where tremor represents one of the most annoying and disabling symptoms since early stages of the disease.

For these reasons, tremor-related pathologies could benefit from HFAC stimulation. To our knowledge, no studies have applied HFAC stimulation in patients with PD. The main objective of this study is to compare the effectiveness of sham stimulation and real stimulation (10kHz) for tremor \[rest tremor, postural tremor, kinetic tremor\] in people with PD. Secondary objectives include analyzing the effectiveness of stimulation for fine motor skills and maximal isometric grip strength in people with PD, as well as documenting adverse events and evaluating blinding success.

A double-blind, randomized, crossover-design study will be conducted at the University of Castilla-La Mancha. Two interventions will be performed in people with Parkinson's Disease during "Off" state, randomizing the order: Intervention A: 10kHz stimulation; Intervention B: sham electrical stimulation.
Detailed Description: High-frequency alternating current HFAC stimulation involves applying electrical stimulation with a frequency above 1 kilohertz kHz to peripheral nerves inducing immediate reversible nerve block without causing damage Studies have shown that frequencies between 10 and 20 kHz reduce maximal isometric grip strength when applied transcutaneously over peripheral nerves suggesting a partial block of A-alpha fibers which may help reduce nerve hyperexcitability and motor activity Tremor-related pathologies influenced by abnormal muscle activity significantly impact the quality of life of patients particularly those with Parkinsons disease PD where tremor represents one of the most annoying and disabling symptoms since early stages of the disease

For these reasons tremor-related pathologies could benefit from HFAC stimulation To our knowledge no studies have applied HFAC stimulation in patients with PD The main objective of this study is to compare the effectiveness of sham stimulation and real stimulation 10kHz for tremor rest tremor postural tremor kinetic tremor in people with PD Secondary objectives include analyzing the effectiveness of stimulation for fine motor skills and maximal isometric grip strength in people with PD as well as documenting adverse events and evaluating blinding success

A double-blind randomized crossover-design study will be conducted at the University of Castilla-La Mancha Two interventions will be performed in people with Parkinsons Disease during Off state randomizing the order Intervention A 10kHz stimulation Intervention B sham electrical stimulation

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
MCIN1013039501100011033 OTHER Ministery of science and innovation of Spain None